Abstract: A dual-fuel internal combustion engine includes: cylinders for combusting a first liquid fuel having a first ignitability in a first operating mode, and a second liquid fuel having a second lesser ignitability, in a second operating mode; a main injection system including a main injector for each cylinder, for feeding the first liquid fuel to the respective cylinders in the first operating mode and for feeding the second liquid fuel to the respective cylinders in the second operating mode; and a pilot injection system including a pilot injector for each cylinder, via which the first liquid fuel can is feedable to the respective cylinders in the second operating mode for igniting the second liquid fuel. The main and pilot injection systems are coupled such that in the second operating mode the first liquid fuel, is feedable to the respective main injector as a working fluid and/or a barrier fluid.

Abstract: A dual-fuel internal combustion engine includes: cylinders for combusting a first liquid fuel having a first ignitability in a first operating mode, and a second liquid fuel having a second lesser ignitability, in a second operating mode; a main injection system including a main injector for each cylinder, for feeding the first liquid fuel to the respective cylinders in the first operating mode and for feeding the second liquid fuel to the respective cylinders in the second operating mode; and a pilot injection system including a pilot injector for each cylinder, via which the first liquid fuel can is feedable to the respective cylinders in the second operating mode for igniting the second liquid fuel. The main and pilot injection systems are coupled such that in the second operating mode the first liquid fuel, is feedable to the respective main injector as a working fluid and/or a barrier fluid.

Abstract: An injector for a fuel supply system of an internal combustion engine, namely for a common rail fuel supply system of an internal combustion engine which is formed in particular as a large diesel internal combustion engine or ship's diesel internal combustion engine, having an injection nozzle, a control valve and a retaining body. The injection nozzle and the control valve form a clamped composite, and the composite formed of the injection nozzle and control valve can be mounted on the retaining body as a unit and disassembled from the retaining body as a unit.

Abstract: An injector for a fuel supply system of an internal combustion engine, namely for a common rail fuel supply system of an internal combustion engine which is formed in particular as a large diesel internal combustion engine or ship's diesel internal combustion engine, having an injection nozzle, a control valve and a retaining body. The injection nozzle and the control valve form a clamped composite, and the composite formed of the injection nozzle and control valve can be mounted on the retaining body as a unit and disassembled from the retaining body as a unit.

Abstract: Fuel is conveyed by at least one high-pressure pump from a low-pressure region into a high-pressure region including a pressure-accumulator line consisting of at least two separate accumulator units connected to one another by means of feed lines, and to fuel injectors for the cylinders. The accumulator units each have an accumulator volume for serving at least two cylinders, and accumulator covers provided on both end faces. All the functional units are integrated into these accumulator covers in terms of fuel delivery and transfer, and at least one separate pump accumulator is arranged in the high-pressure region between the high-pressure pump and the assembled pressure-accumulator line. The pump accumulator is connected to at least one accumulator cover of an accumulator unit of the pressure-accumulator line for fuel conveyance and is capable of being acted upon by at least one high-pressure pump.

Abstract: Fuel is conveyed by at least one high-pressure pump from a low-pressure region into a high-pressure region including a pressure-accumulator line consisting of at least two separate accumulator units connected to one another by means of feed lines, and to fuel injectors for the cylinders. The accumulator units each have an accumulator volume for serving at least two cylinders, and accumulator covers provided on both end faces. All the functional units are integrated into these accumulator covers in terms of fuel delivery and transfer, and at least one separate pump accumulator is arranged in the high-pressure region between the high-pressure pump and the assembled pressure-accumulator line. The pump accumulator is connected to at least one accumulator cover of an accumulator unit of the pressure-accumulator line for fuel conveyance and is capable of being acted upon by at least one high-pressure pump.

Abstract: An apparatus and method for feeding a stream of underlap-imbricated sheet-like printing substrates to printing machine, the apparatus comprising a conveying table for conveying the stream in a conveying direction toward the printing, a source of compressed air, and at least one blowing device coupled to the source of compressed air, the blowing device being disposed in a region of the conveying table adjacent to printing machine, and including at least one opening disposed to direct compressed air beneath the imbricated stream in a direction opposite to the conveying direction.

Abstract: P-substituted aminoalkylphosphinic acids of the formula ##STR1## wherein R denotes an optionally fluorinated methyl group, R.sub.1 denotes hydrogen, lower alkyl, lower alkoxy, hydroxy, halogen or a fluorinated methyl group and R.sub.2 and R.sub.3 denote hydrogen or R.sub.2 denotes hydroxy, lower alkoxy or halogen and R.sub.3 is hydrogen or R.sub.2 and R.sub.3 together represent an oxo group, and their pharmaceutically acceptable salts are active as GABA.sub.B -agonists and can be used in the treatment of spinal spasticity, multiple sclerosis and cerebral palsy, trigeminus neuralgia, drug withdrawal syndromes and/or conditions of pain. They can be manufactured by methods known per se and suitable such methods are described.

Abstract: P-substituted aminoalkylphosphinic acids of the formula ##STR1## wherein R denotes an optionally fluorinated methyl group, R.sub.1 denotes hydrogen, lower alkyl, lower alkoxy, hydroxy, halogen or a fluorinated methyl group and R.sub.2 and R.sub.3 denote hydrogen or R.sub.2 denotes hydroxy, lower alkoxy or halogen and R.sub.3 is hydrogen or R.sub.2 and R.sub.3 together represent an oxo group, and their pharmaceutically acceptable salts are active as GABA.sub.b -agonists and can be used in the treatment of spinal spasticity, multiple sclerosis and cerebral palsy, trigeminus neuralgia, drug withdrawal syndromes and/or conditions of pain. They can be manufactured by methods known per se and suitable such methods are described.

Abstract: Compounds of the formula I ##STR1## wherein R denotes an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic or araliphatic radical having 2 or more carbon atoms, and wherein one of the groups R.sup.1, R.sup.2 and R.sup.3 represents hydrogen or an aliphatic, cycloaliphatic, araliphatic or aromatic radical, another one of R.sup.1, R.sup.2 and R.sup.3 is hydrogen or, in the case of R.sup.1 and R.sup.2, is hydroxy, and the remaining one of R.sup.1, R.sup.2 and R.sup.3 is hydrogen, or wherein R denotes methyl, R.sub.1 denotes hydrogen or hydroxy, R.sub.2 denotes an aromatic radical and R.sub.3 represents hydrogen, and their salts have GABA.sub.B -antagonistic properties and can be used as GABA.sub.B -antagonists. They are obtained when in a compound of formula II ##STR2## in which R, R.sup.1, R.sup.2 and R.sup.3 have their previous significances, Z represents --NH.sub.2 and R.sup.4 denotes a hydroxy-protective group R.sup.5 or, when R.sup.1 and R.sup.3 denote hydrogen and R.sup.

Abstract: P-substituted aminoalkylphosphinic acids of the formula ##STR1## wherein R denotes an optionally fluorinated methyl group, R.sub.1 denotes hydrogen, lower alkyl, lower alkoxy, hydroxy, halogen or a fluorinated methyl group and R.sub.2 and R.sub.3 denote hydrogen or R.sub.2 denotes hydroxy, lower alkoxy or halogen and R.sub.3 is hydrogen or R.sub.2 and R.sub.3 together represent an oxo group, and their pharmaceutically acceptable salts are active as GABA.sub.B.sup.- agonists and can be used in the treatment of spinal spasticity, multiple sclerosis and cerebral palsy, trigeminus neuralgia, drug withdrawal syndromes and/or conditions of pain. They can be manufactured by methods known per se and suitable such methods are described.

Abstract: Compounds of the formula I ##STR1## wherein R denotes an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic or araliphatic radical having 2 or more carbon atoms, and wherein one of the groups R.sup.1, R.sup.2 and R.sup.3 represents hydrogen or an aliphatic, cycloaliphatic, araliphatic or aromatic radical, another one of R.sup.1, R.sup.2 and R.sup.3 is hydrogen or, in the case of R.sup.1 and R.sup.2, is hydroxy, and the remaining one of R.sup.1, R.sup.2 and R.sup.3 is hydrogen, or wherein R denotes methyl, R.sub.1 denotes hydrogen or hydroxy, R.sub.2 denotes an aromatic radical and R.sub.3 represents hydrogen, and their salts have GABA.sub.B -antagonistic properties and can be used as GABA.sub.B -antagonists. They are obtained when in a compound of formula II ##STR2## in which R, R.sup.1, R.sup.2 and R.sup.3 have their previous significances, Z represents --NH.sub.2 and R.sup.4 denotes a hydroxy-protective group R.sup.5 or, when R.sup.1 and R.sup.3 denote hydrogen and R.sup.

Abstract: Compounds of formula I ##STR1## wherein R and R.sub.1 are each independently C.sub.1 -C.sub.4 alkoxy or hydroxy and X and Y are as defined herein, as well as the metal, ammonium or substituted ammonium salts thereof, are useful insecticides, acaricides and, in particular, fungicides. They can be applied to plants or to the locus thereof in the form of compositions or used as seed dressings.

Abstract: The invention relates to cycloolefinic complexes of platinum, processes for preparing the same from platinum(II) compounds and cyclolefins having at least 12 ring carbon atoms and at least two aliphatic non-cumulated carbon-carbon double bonds and their use as a catalyst for the addition of Si-bonded hydrogen to an aliphatic multiple bond.

Abstract: Compounds of the formula I ##STR1## wherein R denotes an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic or araliphatic radical having 2 or more carbon atoms, and wherein one of the groups R.sup.1, R.sup.2 and R.sup.3 represents hydrogen or an aliphatic, cycloaliphatic, araliphatic or aromatic radical, another one of R.sup.1, R.sup.2 and R.sup.3 is hydrogen or, in the case of R.sup.1 and R.sup.2, is hydroxy, and the remaining one of R.sup.1, R.sup.2 and R.sup.3 is hydrogen, or wherein R denotes methyl, R.sub.1 denotes hydrogen or hydroxy, R.sub.2 denotes an aromatic radical and R.sub.3 represents hydrogen, and their salts have GABA.sub.B -antagonistic properties and can be used as GABA.sub.B -antagonists. They are obtained when in a compound of formula II ##STR2## in which R, R.sup.1, R.sup.2 and R.sup.3 have their previous significances, Z represents --NH.sub.2 and R.sup.4 denotes a hydroxy-protective group R.sup.5 or, when R.sup.1 and R.sup.3 denote hydrogen and R.sup.

Abstract: Compounds of the formula I ##STR1## wherein R denotes an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic or araliphatic radical having 2 or more carbon atoms, and wherein one of the groups R.sup.1, R.sup.2 and R.sup.3 represents hydrogen or an aliphatic, cycloaliphatic, araliphatic or aromatic radical, another one of R.sup.1, R.sup.2 and R.sup.3 is hydrogen or, in the case of R.sup.1 and R.sup.2, is hydroxy, and the remaining one of R.sup.1, R.sup.2 and R.sup.3 is hydrogen, or wherein R denotes methyl, R.sub.1 denotes hydrogen or hydroxy, R.sub.2 denotes an aromatic radical and R.sub.3 represents hydrogen, and their salts have GABA.sub.B -antagonistic properties and can be used as GABA.sub.B -antagonists. They are obtained when in a compound of formula II ##STR2## in which R, R.sup.1, R.sup.2 and R.sup.3 have their previous significances, Z represents --NH.sub.2 and R.sup.4 denotes a hydroxy-protective group R.sup.5 or, when R.sup.1 and R.sup.3 denote hydrogen and R.sup.

Abstract: Compounds of the formula I ##STR1## wherein R denotes an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic or araliphatic radical having 2 or more carbon atoms, and wherein one of the groups R.sup.1, R.sup.2 and R.sup.3 represents hydrogen or an aliphatic, cycloaliphatic, araliphatic or aromatic radical, another one of R.sup.1, R.sup.2 and R.sup.3 is hydrogen or, in the case of R.sup.1 and R.sup.2, is hydroxy, and the remaining one of R.sup.1, R.sup.2 and R.sup.3 is hydrogen, and their salts have GABA.sub.B -antagonistic properties and can be used as GABA.sub.B -antagonists. They are obtained when in a compound of formula II ##STR2## in which R, R.sup.1, R.sup.2 and R.sup.3 have their previous significances, Z represents --NH.sub.2 and R.sup.4 denotes a hydroxy-protective group R.sup.5 or, when R.sup.1 and R.sup.3 denote hydrogen and R.sup.2 denotes hydrogen or alkyl, denotes an alkali metal or ammonium ion R.sup.6, or Z represents a protected or latent amino group Z.sup.0 and R.sup.

Abstract: The invention relates to salts of the pyrophosphorus acid of formula I ##STR1## wherein X.sym. is a cation equivalent selected from the group consisting of sodium, potassium, lithium, beryllium, magnesium, aluminum, zinc, manganese, copper and NH.sub.4, to the preparation thereof and to novel compounds of formula I, to the use of compounds of formula I as microbicides and as seed dressing agents.

Abstract: A process for preparing poly-(imidesiloxanes) which comprises reacting an N,N'-dialkenyldiimide with an organosilicon compound containing two Si-bonded hydrogen atoms in the presence of a catalyst which promotes the addition of Si-bonded hydrogen to an aliphatic multiple bond.

Abstract: The invention relates to salts of the pyrophosphorous acid of formula I ##STR1## wherein X.sym. is a cation equivalent selected from the group consisting of sodium, potassium, lithium, beryllium, magnesium, aluminum, zinc, manganese, copper and NH.sub.4, to the preparation thereof and to novel compounds of formula I, to the use of compounds of formula I as microbicides and as seed dressing agents.